Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

243.59
+2.761.15%
Post-market: 243.590.00000.00%19:34 EDT
Volume:602.27K
Turnover:146.46M
Market Cap:15.81B
PE:16.65
High:244.36
Open:242.93
Low:241.76
Close:240.83
52wk High:266.38
52wk Low:124.47
Shares:64.91M
Float Shares:62.69M
Volume Ratio:0.99
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.29
PE(LYR):-41.71

Loading ...

Jazz Pharma director Bruce C. Cozadd disposes of 6,000 shares for USD 1.41 million

Reuters
·
Jun 04

Jazz Pharmaceuticals (JAZZ) Gets a Hold from Bernstein

TIPRANKS
·
Jun 02

Jazz Pharma EVP, Chief Legal Officer Neena Patil disposes of USD 282,870.24 in common shares

Reuters
·
Jun 02

Jazz Pharma EVP, Chief Commercial Officer Samantha Pearce sells 6,907 shares for $1.63 million

Reuters
·
Jun 02

Jazz Pharma director Anne O'Riordan will not seek re-election at 2026 annual meeting

Reuters
·
May 30

Jazz Pharma director Rick E. Winningham disposes of 2,741 shares for $661,744.37

Reuters
·
May 28

Jazz director Heather Ann McSharry disposes of Jazz Pharma shares worth $482,000

Reuters
·
May 28

Jazz Pharmaceuticals Phase 3 HERIZON-GEA-01 results published in NEJM

TIPRANKS
·
May 28

Jazz Pharmaceuticals Is Maintained at Overweight by Barclays

Dow Jones
·
May 28

Jazz Pharmaceuticals (JAZZ) Receives a Buy from Barclays

TIPRANKS
·
May 27

CTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts

TIPRANKS
·
May 23

Jazz Pharmaceuticals Is Maintained at Overweight by Piper Sandler

Dow Jones
·
May 22

Bernstein Initiates Coverage on Jazz Pharmaceuticals With Market Perform Rating

MT Newswires Live
·
May 22

U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday

Reuters
·
May 22

Jazz Pharmaceuticals Plc : Piper Sandler Raises Target Price to $301 From $232

THOMSON REUTERS
·
May 22

Bernstein starts Jazz at Market Perform, says clock ticking on blockbuster drugs

TIPRANKS
·
May 22

J.P. Morgan Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
May 20

U.S. RESEARCH ROUNDUP-CAVA Group, Eagle Materials, Vertiv

Reuters
·
May 20

Jazz Pharmaceuticals Plc : JP Morgan Resumes Coverage With Overweight Rating; Price Target $265

THOMSON REUTERS
·
May 20

Jazz Pharmaceuticals Raised to Buy From Neutral by UBS

Dow Jones
·
May 19